Henry ScheinHSIC
About: Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Employees: 25,000
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
652% more call options, than puts
Call options by funds: $117M | Put options by funds: $15.6M
30% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 71
10% more funds holding in top 10
Funds holding in top 10: 10 [Q4 2024] → 11 (+1) [Q1 2025]
2% more funds holding
Funds holding: 536 [Q4 2024] → 548 (+12) [Q1 2025]
0.8% less ownership
Funds ownership: 102.63% [Q4 2024] → 101.83% (-0.8%) [Q1 2025]
3% less capital invested
Capital invested by funds: $8.86B [Q4 2024] → $8.63B (-$224M) [Q1 2025]
23% less repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 208
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
Wells Fargo Vik Chopra | 4%upside $75 | Equal-Weight Maintained | 6 May 2025 |
Barrington Research Michael Petusky | 20%upside $86 | Outperform Maintained | 6 May 2025 |
Piper Sandler Jason Bednar | 7%upside $77 | Overweight Maintained | 30 Apr 2025 |
UBS Kevin Caliendo | 11%upside $80 | Neutral Maintained | 26 Feb 2025 |
Financial journalist opinion
Based on 15 articles about HSIC published over the past 30 days









